Shopping Cart
- Remove All
- Your shopping cart is currently empty
Benzquinamide (P2647), an antiemetic agent with anticancer activity, inhibits p-glycoprotein-mediated drug efflux and potentiates the cytotoxicity of anticancer drugs in multidrug-resistant cells.The Ki values of Benzquinamide for α2A, α2B, and α2C adrenergic receptor (α2-AR) were 1,365, 691, and 545 nM, respectively. 545 nM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $700 | Backorder | |
5 mg | $1,800 | Backorder |
Description | Benzquinamide (P2647), an antiemetic agent with anticancer activity, inhibits p-glycoprotein-mediated drug efflux and potentiates the cytotoxicity of anticancer drugs in multidrug-resistant cells.The Ki values of Benzquinamide for α2A, α2B, and α2C adrenergic receptor (α2-AR) were 1,365, 691, and 545 nM, respectively. 545 nM, respectively. |
Targets&IC50 | α2A:1,365 nM (Ki), α2B:691 nM (Ki), α2C:545 nM (Ki) |
Alias | P2647, BZQ, Benzoquinamide |
Molecular Weight | 404.5 |
Formula | C22H32N2O5 |
Cas No. | 63-12-7 |
Smiles | CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O |
Relative Density. | 1.19 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.